Bashar T, Akhter N
Bangladesh Med Res Counc Bull. 2014 Aug;40(2):79-84. doi: 10.3329/bmrcb.v40i2.25226.
In acute myocardial infarction (AMI), lack of oxygen delivery to myocardium leads to generation of reactive oxygen species (ROS) which play an important role in the pathogenesis of AMI. Endogenous anti-oxidants protect the myocardial tissues from the deleterious effect of free radical mediate injury. The study evaluates the extent of oxidative stress and antioxidant status against ROS in AMI patients and amelioration of oxidative stress after regular treatment and also assesses the association between oxidative stress and risk factors for atherosclerosis like dyslipidemia and diabetes mellitus (DM). The study was conducted on 72 AMI patients and age and sex matched 18 healthy controls. Patients were assigned to four groups, AMI without dyslipidemia or DM, with dyslipidemia, with DM and with both dyslipidemia and DM. Plasma malondialdehyde (MDA) and GSH content and vitamin E levels were determined on admission into hospital and on the 5th day of treatment. Plasma MDA level increased significantly (p < 0.001) and erythrocyte GSH and plasma vitamin E levels were decreased (p < 0.001) in all the groups of patients as compared to control. On the 50th day of regular treatment MDA level reduced (p < 0.001) and GSH and vitamin E levels increased (p < 0.001) in patients. The plasma MDA level was significantly higher (p < 0.001) in patients with both dyslipidemia and DM or with only DM in comparison to patients without dyslipidemia and DM. The difference in the GSH level between patients with risk factors and without risk factors was not significant. It may be conclude that an imbalance exists between oxidant and antioxidant molecules in AMI patients which shift towards oxidative side and regular treatment restores this balance. There may be some association between oxidative stress in AMI and risk factors like dyslipidemia and diabetes mellitus.
在急性心肌梗死(AMI)中,心肌供氧不足会导致活性氧(ROS)的产生,而ROS在AMI的发病机制中起重要作用。内源性抗氧化剂可保护心肌组织免受自由基介导损伤的有害影响。本研究评估了AMI患者中氧化应激的程度以及针对ROS的抗氧化状态,以及常规治疗后氧化应激的改善情况,还评估了氧化应激与动脉粥样硬化危险因素(如血脂异常和糖尿病(DM))之间的关联。该研究对72例AMI患者以及年龄和性别匹配的18名健康对照者进行。患者被分为四组:无血脂异常或DM的AMI患者、有血脂异常的患者、有DM的患者以及同时有血脂异常和DM的患者。在入院时和治疗第5天时测定血浆丙二醛(MDA)、谷胱甘肽(GSH)含量和维生素E水平。与对照组相比,所有患者组的血浆MDA水平显著升高(p < 0.001),红细胞GSH和血浆维生素E水平降低(p < 0.001)。在常规治疗第50天时,患者的MDA水平降低(p < 0.001),GSH和维生素E水平升高(p < 0.001)。与无血脂异常和DM的患者相比,同时有血脂异常和DM或仅有DM的患者血浆MDA水平显著更高(p < 0.001)。有危险因素和无危险因素患者之间的GSH水平差异不显著。可以得出结论,AMI患者体内氧化剂和抗氧化剂分子之间存在失衡,这种失衡向氧化方向偏移,而常规治疗可恢复这种平衡。AMI中的氧化应激与血脂异常和糖尿病等危险因素之间可能存在某种关联。